Metropolitan Life Insurance Company (MetLife)’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,153
| Closed | -$106K | – | 1595 |
|
|
2024
Q1 | $106K | Sell |
2,153
-161
| -7% | -$7.96K | ﹤0.01% | 1014 |
|
|
2023
Q4 | $97K | Buy |
2,314
+139
| +6% | +$5.83K | ﹤0.01% | 1102 |
|
|
2023
Q3 | $71.4K | Buy |
2,175
+186
| +9% | +$6.1K | ﹤0.01% | 1199 |
|
|
2023
Q2 | $70.3K | Buy |
1,989
+570
| +40% | +$20.1K | ﹤0.01% | 1217 |
|
|
2023
Q1 | $40.3K | Sell |
1,419
-182
| -11% | -$5.17K | ﹤0.01% | 1520 |
|
|
2022
Q4 | $66.5K | Hold |
1,601
| – | – | ﹤0.01% | 1306 |
|
|
2022
Q3 | $66.4K | Hold |
1,601
| – | – | ﹤0.01% | 1271 |
|
|
2022
Q2 | $52.3K | Buy |
1,601
+1,014
| +173% | +$33.1K | ﹤0.01% | 1478 |
|
|
2022
Q1 | $20.5K | Buy |
+587
| New | +$20.5K | ﹤0.01% | 2082 |
|